High risk behavior for HIV transmission among former injecting drug users: A survey from Indonesia

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Iskandar, Shelly ^a   Basar, Diba ^a   Hidayat, Teddy ^a   Siregar, Ike Mp ^a   Pinxten, Lucas ^a,b   Van Crevel, Reinout ^a,c   Van Der Ven, Andre Jam ^a,c   De Jong, Cor Aj ^d  

^a PADJADJARAN UNIVERSITY   (Indonesia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Nijmegen Institute for Scientist Practitioners in Addiction   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOODBORNE BACTERIUM; BODY PIERCING; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; INTERVIEW; MALE; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEXUAL BEHAVIOR; STATISTICS; SUBSTANCE ABUSE; TATTOOING; TIME; URBAN POPULATION;

ADULT; BLOOD-BORNE PATHOGENS; BODY PIERCING; CHI-SQUARE DISTRIBUTION; FEMALE; HIV INFECTIONS; HUMANS; INDONESIA; INTERVIEWS AS TOPIC; MALE; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE, INTRAVENOUS; TATTOOING; TIME FACTORS; URBAN POPULATION;

EID: 77955295557     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-472     Document Type: Article

References (31)

1. At risk and neglected: four key populations. UNAIDS, Geneva: UNAIDS, rotgAeAUtas, 2006 2006
2. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. DC Des Jarlais K Arasteh T Perlis H Hagan A Abdul-Quader DD Heckathorn C McKnight H Bramson C Nemeth LV Torian, et al. AIDS 2007 21 2 231 235 10.1097/QAD.0b013e3280114a15 17197815
3. Twelve-month outcomes for heroin dependence treatments: does route of administration matter? S Darke J Ross M Teesson, Drug Alcohol Rev 2005 24 2 165 171 10.1080/09595230500102657 16076586
4. Country Report on The Follow Up to The Declaration of Commitment on HIV/AIDS: UNGASS Reporting Period 2006-2007. NAC, Committee NA, 2007
5. Sexual behavior among injection drug users in 3 indonesian cities carries a high potential for HIV spread to noninjectors. E Pisani Dadun PK Sucahya O Kamil S Jazan, J Acquir Immune Defic Syndr 2003 34 4 403 406 10.1097/00126334-200312010-00007 14615658
6. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City. DC Des Jarlais K Arasteh T Perlis H Hagan DD Heckathorn C McKnight H Bramson SR Friedman, Addiction 2007 102 5 778 785 10.1111/j.1360-0443.2007.01764.x 17506155
7. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. A Neaigus VA Gyarmathy M Zhao M Miller SR Friedman DC Des Jarlais, J Infect Dis 2007 195 7 1052 1061 10.1086/512081 17330797
8. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. S Tortu JM McMahon ER Pouget R Hamid, Subst Use Misuse 2004 39 2 211 224 10.1081/JA-120028488 15061559
9. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. VA Gyarmathy A Neaigus M Miller SR Friedman DC Des Jarlais, J Acquir Immune Defic Syndr 2002 30 4 448 456 12138352
10. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. A Neaigus M Miller SR Friedman DL Hagen SJ Sifaneck G Ildefonso DC des Jarlais, Addiction 2001 96 6 847 860 10.1046/j.1360-0443.2001.9668476.x 11399216
11. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. DD Heckathorn S Semaan RS Broadhead JJ Hughes, AIDS Behav 2002 6 1 55 67 10.1023/A:1014528612685
12. Sampling and Estimation in Hidden Populations Using Respondent Driven Sampling. MJ Salganik DD Heckathorn, Sociol Method 2004 34 193 240 10.1111/j.0081-1750.2004.00152.x
13. Prevention, Control, and Treatment of HIV-AIDS among Injecting Drug User in Bandung, Indonesia. B Alisjahbana H Susanto R Roesli H Yusuf Z Hinduan JC Mose E Surahman Avd Ven, Acta Med Indones 2009 41 Supplement 1 65 69
14. Addiction Severity Index: Manual and Question by Question Guide. http://www.tresearch.org/resources/manuals/ASIQbyQGuide.pdf
15. The Addiction Severity Index at 25: origins, contributions and transitions. AT McLellan JS Cacciola AI Alterman SH Rikoon D Carise, Am J Addict 2006 15 2 113 124 10.1080/10550490500528316 16595348
16. WHO Collaborative Study on Substitution Therapy of Opioid Dependence and HIV/AIDS: General Protocol. http://www.who.int/substance-abuse/research-tools/ translation/en/print.html
17. Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). CL Fry N Lintzeris, Addiction 2003 98 2 171 178 10.1046/j.1360-0443.2003.00207.x 12534421
18. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. T Tucker CL Fry N Lintzeris S Baldwin A Ritter S Donath G Whelan, Addiction 2004 99 9 1157 1166 10.1111/j.1360-0443.2004.00809.x 15317636
19. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. R Wisaksana AK Indrati A Fibriani E Rogayah P Sudjana TS Djajakusumah R Sumantri B Alisjahbana A van der Ven R van Crevel, Addiction (Abingdon, England) 2010 20331555
20. HIV and Injecting Drug Use in Indonesia: Epidemiology and National Response. I Afriandi TY Aditama D Mustikawati M Oktavia B Alisjahbana P Riono, Acta Med Indones 2009 41 Supplement 1 75 78 19390126
21. HIV/STI Integrated Biological Behavioral Surveillance (IBBS) among Most-at-Risk Group (MARG) in Indonesia. MoH NAC USAID ASA FHI, Ministry of Health, National AIDS Committee, Family Health International 2007
22. Preventing HIV transmission among injecting drug users (IDUs) and from IDUs to noninjecting sexual partners in Sichuan, China. DC Des Jarlais, Sex Transm Dis 2007 34 8 583 585 10.1097/OLQ.0b013e3180646412 17667533
23. Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up. M Gossop J Marsden D Stewart T Kidd, Addict Behav 2003 28 4 785 793 10.1016/S0306-4603(01)00279-9 12726791
24. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. P Lawrinson R Ali A Buavirat S Chiamwongpaet S Dvoryak B Habrat S Jie R Mardiati A Mokri J Moskalewicz, et al. Addiction 2008 103 9 1484 1492 10.1111/j.1360-0443.2008.02249.x 18636999
25. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. P Roux V Villes J Blanche D Bry B Spire I Feroni MP Carrieri, Drug Alcohol Depend 2008 97 1-2 105 113 10.1016/j. drugalcdep.2008.03.025 18479840
26. Alcohol and HIV sexual risk behaviors among injection drug users. K Arasteh DC Des Jarlais TE Perlis, Drug Alcohol Depend 2008 95 1-2 54 61 10.1016/j.drugalcdep.2007.12.008 18242009
27. Methamphetamine dependence and human immunodeficiency virus risk behavior. RA Rawson R Gonzales V Pearce A Ang P Marinelli-Casey J Brummer, J Subst Abuse Treat 2008 35 3 279 284 10.1016/j.jsat.2007.11.003 18329225
28. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. A Neaigus VA Gyarmathy M Miller V Frajzyngier M Zhao SR Friedman DC Des Jarlais, Drug Alcohol Depend 2007 89 2-3 234 243 10.1016/j.drugalcdep.2007.01.003 17289298
29. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. L Platt M Wall T Rhodes A Judd M Hickman LG Johnston A Renton N Bobrova A Sarang, J Urban Health 2006 83 6 Suppl 39 53 10.1007/s11524-006-9101-2 17096189
30. Network models for HIV outreach and prevention programs for drug users. RT Trotter II AM Bowen JM Potter Jr, NIDA Res Monogr 1995 151 144 180 8742765
31. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. E Wood T Kerr BD Marshall K Li R Zhang RS Hogg PR Harrigan JS Montaner, BMJ 2009 338 1649 10.1136/bmj.b1649 19406887